Shuttle Pharmaceuticals Holdings (SHPH) Treasury Shares (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Treasury Shares came in at $106891.0 in Q1 2026, down 86.59% year-on-year from $796925.0 in Q1 2025, and down 29.52% quarter-over-quarter from $151657.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Treasury Shares (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Treasury Shares history runs 6 years deep, the most recent figure standing at $106891.0 for Q1 2026.
- On a quarterly basis, Treasury Shares fell 86.59% year-over-year to $106891.0 in Q1 2026; TTM through Mar 2026 was $106891.0, a 86.59% decrease from a year earlier, with the FY2025 full-year figure at $151657.0, up 249.55% from the prior year.
- Treasury Shares retreated to $106891.0 in Q1 2026 per SHPH's latest filing, from $151657.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $796925.0 in Q1 2025 and bottomed at $2966.0 in Q4 2022.
- The 5-year median for Treasury Shares is $51112.5 (2024), against an average of $123851.9.
- Across the five-year window, Treasury Shares jumped 2236.61% in 2025 and slumped 86.59% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $2966.0 in 2022, then jumped by 733.82% to $24731.0 in 2023, then soared by 75.43% to $43386.0 in 2024, then jumped by 249.55% to $151657.0 in 2025, then retreated by 29.52% to $106891.0 in 2026.
- Per Business Quant, the three latest SHPH Treasury Shares figures stand at $106891.0 (Q1 2026), $151657.0 (Q4 2025), and $166822.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 106,891.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,891.00 |
| Mar 31, 2026 | 106,891.00 |
| Dec 31, 2025 | 151,657.00 |
| Dec 31, 2025 | 151,657.00 |
| Sep 30, 2025 | 166,822.00 |
| Sep 30, 2025 | 166,822.00 |
| Jun 30, 2025 | 31,442.00 |
| Jun 30, 2025 | 31,442.00 |
| Mar 31, 2025 | 796,925.00 |
| Mar 31, 2025 | 796,925.00 |
| Dec 31, 2024 | 43,386.00 |
| Dec 31, 2024 | 43,386.00 |
| Sep 30, 2024 | 41,338.00 |
| Sep 30, 2024 | 41,338.00 |
| Jun 30, 2024 | 58,839.00 |
| Jun 30, 2024 | 58,839.00 |
| Mar 31, 2024 | 34,106.00 |
| Mar 31, 2024 | 34,106.00 |
| Dec 31, 2023 | 24,731.00 |
| Dec 31, 2023 | 24,731.00 |